Drug recall D-0125-2025

Class II Ongoing reported Dec 18, 2024

Product

Levothyroxine Sodium Tablets USP, 75 mcg, packaged in a) 90-count bottles (NDC 0378-1805-77) and b) 1000-count bottles (NDC 0378-1805-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.

Reason for recall

Superpotent Drug and Subpotent Drug: potency failures obtained

Lots and codes

Lot #: a) 8177078, Exp. Date May 2025; 8168596, Exp. Date Jan 2025 b) 3199313, Exp. Date May 2025; 3194118, Exp. Date Mar 2025; 3186238, Exp. Date Dec 2024; 3209590, Exp. Date Sep 2025; 3199317, Exp. Date May 2025; 3188733, Exp. Date Jan 2025

Recall details

Recalling firm
Viatris Inc, Canonsburg, PA
Quantity
63,077 bottles
Distribution
Nationwide within the United States and Puerto Rico
Type
Voluntary: Firm initiated
Recall initiated
November 18, 2024

Related products